These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Use of antagonists of aldosterone in patients with chronic kidney disease: Potential advantages and risks. Campese VM; Park J J Hypertens; 2006 Nov; 24(11):2157-9. PubMed ID: 17053534 [No Abstract] [Full Text] [Related]
45. Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials. Shalita AR; Berson DS; Thiboutot DM; Leyden JJ; Parizadeh D; Sefton J; Walker PS; Gibson JR; Clin Ther; 2004 Nov; 26(11):1865-73. PubMed ID: 15639698 [TBL] [Abstract][Full Text] [Related]
46. Efficacy of combined spironolactone and topical retinoids in South Asian women with acne. Tahir A; Khan S; Shah RR; Waqas N; Sharif S; Rao B Clin Dermatol; 2024; 42(1):89-90. PubMed ID: 38008366 [No Abstract] [Full Text] [Related]
47. Oral spironolactone improves acne vulgaris and reduces sebum excretion. Goodfellow A; Alaghband-Zadeh J; Carter G; Cream JJ; Holland S; Scully J; Wise P Br J Dermatol; 1984 Aug; 111(2):209-14. PubMed ID: 6235834 [TBL] [Abstract][Full Text] [Related]
48. Importance of spironolactone in the treatment of acne in adult women. Saint-Jean M; Ballanger F; Nguyen JM; Khammari A; Dréno B J Eur Acad Dermatol Venereol; 2011 Dec; 25(12):1480-1. PubMed ID: 21114688 [No Abstract] [Full Text] [Related]
49. [Treatment of acne with antiandrogens: validity of treatment with spironolactone]. Pizzino D; Bettoli V; Varotti C G Ital Dermatol Venereol; 1987 Nov; 122(11):599-604. PubMed ID: 2966109 [No Abstract] [Full Text] [Related]
50. The efficacy and safety of amoxicillin, trimethoprim-sulfamethoxazole, and spironolactone for treatment-resistant acne vulgaris. Turowski CB; James WD Adv Dermatol; 2007; 23():155-63. PubMed ID: 18159900 [TBL] [Abstract][Full Text] [Related]